Johnson & Johnson earnings: A challenging second quarter poised for a turnaround

Johnson & Johnson’s first-quarter sales miss amid a challenging drug market disappointed investors. Don’t expect the company’s second-quarter earnings — scheduled before the open on July 18 — to be any different, Wall Street analysts say.